Bigul

Record Date For The Purpose Of Buyback Of Equity Shares Of The Company - Tuesday, February 27, 2018

In terms of Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 9(1) of SEBI (Buyback of Securities) Regulations, 1998, we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, February 15, 2018 has finalized the 'Record Date' for the purpose of determining the entitlement and the names of the equity shareholders who shall be eligible to participate...
15-02-2018
Bigul

Record Date For The Purpose Of Buyback Of Equity Shares Of The Company - Tuesday, February 27, 2018

In terms of Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 9(1) of SEBI (Buyback of Securities) Regulations, 1998, we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, February 15, 2018 has finalized the 'Record Date' for the purpose of determining the entitlement and the names of the equity shareholders who shall be eligible to participate...
15-02-2018
Bigul

Corporate Action-Updates on Buy back

Sub.: Filing of Public Announcement and Board Resolution for Buyback of Equity Shares of FDC Limited pursuant to Regulation 8(1) and 5A of Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 1998 as amended ('SEBI Buyback Regulations') With reference to the captioned matter, please find enclosed herewith the following:...
09-02-2018
Bigul

Intimation Of Board Meeting For Fixing The Record Date

This is in continuation to our Letter dated February 07, 2018 informing you about the approval of the Buyback proposal through Tender offer route. In view of the above, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 15, 2018 at Mumbai, for fixing the record date for the purpose of determining the entitlement and the names of the Shareholders, who will be eligible to participate in the said Buyback....
09-02-2018
Bigul

FDC hits 52-week high as board approves buyback; strong Q3 results

The stock hit a 52-week high of Rs 280, up 10%, extending its previous days 6% surge, after the board approved buyback proposal at a price of Rs 350 per equity share through tender offer.
08-02-2018
Bigul

Updates on Buy back

With reference to our Intimation Letter dated February 03, 2018, we wish to inform you that the Board of Directors at its meeting held on February 07, 2018 has inter-alia approved the Buyback proposal for purchase by the Company of its own fully paid up Equity Shares of Re. 1/- each ('Equity Shares') from the equity shareholders of the Company as on the record date to be announced later, not exceeding 3,430,000 fully paid up Equity Shares ( being...
07-02-2018
Bigul

Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2017 Limited Review Report For The Quarter And Nine Months Ended December 31, 2017

This is to inform that the Board of Directors at its meeting held on February 07, 2018 has approved the unaudited financial results of the Company for the quarter and nine months ended December 31, 2017. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, please find enclosed herewith the following:...
07-02-2018
Bigul

FDC gains 7% ahead of board meet for share buyback

The stock was up 7% to Rs 256 on BSE ahead of board meeting today to consider share buyback proposal and unaudited financial results for the quarter ended December 2017.
07-02-2018
Bigul

Intimation of Buy back

This is in continuation to our Letter dated January 09, 2018, intimating that the meeting of the Board of Directors of the Company is scheduled to be held on February 07, 2018 at Mumbai, to inter alia, consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017. In terms of Regulation 29(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure...
03-02-2018
Bigul

Updates

This is to inform you that the Company continues with its approved status from UK MHRA (Medicines and Healthcare Products Regulatory Agency), for its Ophthalmic Manufacturing facility situated at Waluj, Aurangabad, based on recent Good Manufacturing Practice (GMP) inspection held at the said Plant.
25-01-2018
Next Page
Close

Let's Open Free Demat Account